Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan Eduardo Reséndiz-Galván"'
Autor:
Juan Eduardo Reséndiz-Galván, Nadia Hernández-Villa, Lourdes Cecilia Correa-González, Juan José Ortiz-Zamudio, Silvia Romano-Moreno, Miriam Nayeli Morales-Barragán, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia, Karla Paulina Valero-Rivera
Publikováno v:
Cancer Chemotherapy and Pharmacology. 85:21-31
To develop and validate a population pharmacokinetic model of Methotrexate (MTX) in Mexican children with acute lymphoblastic leukemia (ALL) for the design of personalized dosage regimens based on the anthropometric and physiological characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54dcaaf2214f4ea4621b219dc0748166
https://doi.org/10.1007/s00280-019-03977-1
https://doi.org/10.1007/s00280-019-03977-1
Autor:
Melissa Romano-Aguilar, Carlos Abud-Mendoza, Juan Eduardo Reséndiz-Galván, Marco Ulises Martínez-Martínez, Silvia Romano-Moreno, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia
Publikováno v:
Lupus. 29(9)
BackgroundMycophenolic acid (MPA) is an effective oral immunosuppressive drug used to treat lupus nephritis (LN), which exhibits large pharmacokinetic variability. This study aimed to characterize MPA pharmacokinetic behaviour in Mexican LN patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa6191b985f7ea73e567e7a7b10b5828
https://pubmed.ncbi.nlm.nih.gov/32539658
https://pubmed.ncbi.nlm.nih.gov/32539658
Autor:
Juan Eduardo Reséndiz-Galván, Susanna Edith Medellín-Garibay, Melissa Romano-Aguilar, Perla Niño-Moreno, José Alejandro Chevaile-Ramos, Rosa del Carmen Milán-Segovia, Helgi Jung-Cook, Silvia Romano-Moreno
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 150
Mycophenolate mofetil (MMF) is typically used in combination with prednisone and tacrolimus to avoid graft rejection in kidney transplant patients. The aim of this study was to develop and validate a population pharmacokinetic model of mycophenolic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa08f9d10d254b2e1d0505c9179dc33
https://pubmed.ncbi.nlm.nih.gov/32387086
https://pubmed.ncbi.nlm.nih.gov/32387086
Autor:
Silvia Romano-Moreno, Juan Eduardo Reséndiz-Galván, Melissa Romano-Aguilar, Alejandro Chevaile‐Ramos, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia
Publikováno v:
Biomedical chromatography : BMCREFERENCES. 33(12)
To implement and validate an analytical method by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC MS/MS) to quantify mycophenolic acid (MPA) in kidney transplant patients. Quantification of MPA was performed in an ACQUITY UPLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c33fe2ea5e10baac2a88932dff2ab6e
https://pubmed.ncbi.nlm.nih.gov/31419321
https://pubmed.ncbi.nlm.nih.gov/31419321
Autor:
Juan Eduardo Reséndiz-Galván, Susanna Edith Medellín-Garibay, Silvia Romano-Moreno, Rosa del Carmen Milán-Segovia, Perla Niño-Moreno, Javier Isordia‐Segovia
Publikováno v:
Basicclinical pharmacologytoxicology. 124(3)
The aim of this study was to perform a population pharmacokinetic analysis of tacrolimus in Mexican adult kidney transplant patients to analyse the influence of clinical and genetic covariates to propose a dosage regimen. Kidney transplant patients (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092ba88aa368172a11938fc8e3b85207
https://pubmed.ncbi.nlm.nih.gov/30260084
https://pubmed.ncbi.nlm.nih.gov/30260084
Autor:
Juan Eduardo Resendiz-Galvan, Prerna R. Arora, Mahmoud Tareq Abdelwahab, Zarir F. Udwadia, Camilla Rodrigues, Amita Gupta, Paolo Denti, Tester F. Ashavaid, Jeffrey A. Tornheim
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Linezolid is an oxazolidinone used to treat multidrug-resistant tuberculosis (MDR-TB), including in the recently-endorsed shorter 6-month treatment regimens. Due to its narrow therapeutic index, linezolid is often either dose-adjusted or discontinued
Externí odkaz:
https://doaj.org/article/ada9e38b375c4575a3c14663f16b5161